Posted by DreamGuardian > 2020-11-20 00:07 | Report Abuse

Okay also la

Posted by DreamGuardian > 2020-11-20 00:07 | Report Abuse

Boleh juga la

Posted by DreamGuardian > 2020-11-20 00:07 | Report Abuse

Keep surging

Posted by DreamGuardian > 2020-11-20 00:07 | Report Abuse

Good luck

Posted by LiimInvest > 2020-11-20 00:10 | Report Abuse

Tomorrow Fly over 4.50

Posted by LiimInvest > 2020-11-20 00:20 | Report Abuse

Accumulating more

Posted by Sinoboy > 2020-11-20 11:52 | Report Abuse

Looking good. Steady she goes, don't falter

Posted by chshzhd > 2020-11-20 16:59 | Report Abuse

keep..

Posted by JaBerry > 2020-11-23 09:22 | Report Abuse

Yes keep

Posted by NPRA1985 > 2020-11-23 14:00 |

Post removed.Why?

Posted by JaBerry > 2020-11-27 09:36 | Report Abuse

Waiting for vaccines come another distribution income.

Posted by mrmeow > 2020-11-27 09:41 | Report Abuse

AHEALTH has the cold storage facility and has expanded by acquiring more cold facility and prepared for the covid19 vaccines. Don't foget this real making money one, supplying Msia and Singapore, stable & growing business even before covid, always on an uptrend

Posted by mrmeow > 2020-11-27 12:00 | Report Abuse

Everyone looking for logistics company that has cold facility for vaccine distribution, yet they forget that this pharmaceutical company does distribution too and has the logistics capable of doing the real work

Posted by LiimInvest > 2020-11-27 12:47 | Report Abuse

Vaccine-related: Following the approval of Budget 2021, vaccine-related companies will benefit under the Covid-19 fund/fill-and-finish process as well as distribution of vaccines once it is available in the future. Under this segment, SOLUTN, HWGB, BINTAI, DPHARMA, PHARMA, KANGER, -Ahealth, TITIJYA, MAHSING should be under traders radar.

Source: M+ Online

Posted by serendipity89 > 2020-11-28 13:30 | Report Abuse

''Apex has been approached by several manufacturers to be the authorised distributor for their upcoming Covid-19 vaccines (work-in-progress). There are many considerations in evaluating these proposals (ie. whether the products will be approved, pricings, efficiencies, requirements, etc) and hence, Apex has not committed to any manufacturer. Instead, the group will likely start off as a wholesaler, where Apex will distribute the Covid-19 vaccines from various manufacturers''

AffinHWang

Posted by NPRA1985 > 2020-11-29 21:25 | Report Abuse

PM: No call to reject 2021 Budget just to bring about polls

"There is no need to do that (reject the 2021 Budget). If you ask me, I could have yesterday advised the Yang di-Pertuan Agong Al-Sultan Abdullah Ri'ayatuddin Al-Mustafa Billah Shah, to dissolve Parliament so that a general election can be held.

"But we all know that the problem is Covid-19. InsyaAllah, if He allows it, when the pandemic is over, we can hold a general election.

Muhyiddin added that the 2021 Budget, worth RM322.5 billion which was passed at the policy level in Parliament on Thursday, is aimed at easing the burden of the people and restoring the country's economy.

"I hope the 2021 Budget will be approved at the Dewan Rakyat and subsequently at the Dewan Negara. This is to ensure that the people will receive the assistance that they need during this tough time."

https://www.nst.com.my/news/politics/2020/11/645117/pm-no-call-reject-2021-budget-just-bring-about-polls

Posted by NPRA1985 > 2020-11-29 21:36 | Report Abuse

No significant change to reject budget at committee level: Dr M

FORMER Prime Minister (PM) Tun Dr Mahathir Mohamad said no significant change can be achieved if the proposed Budget 2021 is rejected at the committee level debate session.

“Rejecting the budget at the committee level, as it is said to be done, will not bring any significant impact on the government nor the proposed budget.

“It is just an attempt to divert the criticisms of the people who are disappointed with the attitude of the Opposition,” Dr Mahathir said in a statement today.

https://themalaysianreserve.com/2020/11/27/no-significant-change-to-reject-budget-at-committee-level-dr-m/

Posted by weijuin1992 > 2020-12-01 12:08 | Report Abuse

Buy on rumours sell on fact ,it had come so far with rumours ,once confirm news will fly ,sit in if you believe in good company !

Posted by weijuin1992 > 2020-12-01 17:39 | Report Abuse

Reversal to uptrend on small fraction of price yet big indicator to this share as it is not so volatile like the others , good chance striking up again !

Posted by NPRA1985 > 2020-12-02 18:36 | Report Abuse

U.K. Approves Pfizer Coronavirus Vaccine, a First in the West
The emergency approval, ahead of the United States and the European Union, clears the way for Britain to begin mass inoculations. “Help is on its way,” one official said.

https://www.nytimes.com/2020/12/02/world/europe/pfizer-coronavirus-vaccine-approved-uk.html

Posted by NPRA1985 > 2020-12-03 00:36 | Report Abuse

Moderna Covid vaccine can get emergency authorisation approval in 2-3 days after panel meet: CEO

Moderna's vaccine candidate's full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns

https://www.livemint.com/news/world/moderna-covid-vaccine-can-get-emergency-authorisation-approval-in-2-3-days-after-panel-meet-ceo-11606922963960.html

Posted by NPRA1985 > 2020-12-03 00:37 | Report Abuse

US says Covid-19 vaccines ready to be shipped nationwide immediately

https://www.freemalaysiatoday.com/category/world/2020/12/02/us-says-covid-19-vaccines-ready-to-be-shipped-nationwide-immediately/

Posted by NPRA1985 > 2020-12-03 00:37 | Report Abuse

Janssen seeks Health Canada approval for its COVID-19 vaccine

https://www.cbc.ca/news/politics/johnson-johnson-health-canada-approval-1.5823173

Posted by NPRA1985 > 2020-12-03 00:38 | Report Abuse

Johnson & Johnson has started a rolling submission with the European Medicines Agency (EMA) for its single-dose COVID-19 vaccine candidate.

https://www.biopharma-reporter.com/Article/2020/12/01/Johnson-Johnson-start-rolling-review-for-COVID-19-vaccine-in-Europe

Posted by NPRA1985 > 2020-12-03 22:25 | Report Abuse

Promise of Covid vaccines is ‘phenomenal’, WHO says

https://www.freemalaysiatoday.com/category/world/2020/12/03/promise-of-covid-vaccines-is-phenomenal-who-says/

Posted by NPRA1985 > 2020-12-03 22:47 | Report Abuse

Equities up as Covid-19 cases drop, vaccine news spurs economic recovery bets

https://www.theedgemarkets.com/article/fbm-klci-closes-2954-points-162826

Posted by NPRA1985 > 2020-12-05 01:33 | Report Abuse

DUBAI: Bahrain said on Friday it has granted emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, becoming the second country after Britain to approve it.

The kingdom had also approved Sinopharm’s COVID-19 vaccine in November for use by frontline workers.

https://www.arabnews.com/node/1772516/middle-east

Posted by NPRA1985 > 2020-12-05 01:46 | Report Abuse

South Korea reaches deal to buy AstraZeneca's Covid-19 vaccine candidate

https://www.straitstimes.com/asia/east-asia/south-korea-reaches-deal-to-buy-astrazenecas-covid-19-vaccine-candidate

Posted by NPRA1985 > 2020-12-05 14:34 | Report Abuse

500 million vaccine doses in Q1 2021 closer to reality, says WHO

https://www.freemalaysiatoday.com/category/world/2020/12/05/500-million-vaccine-doses-in-q1-2021-closer-to-reality-says-who/

Posted by NPRA1985 > 2020-12-09 15:12 | Report Abuse

UAE says Sinopharm vaccine has 86% efficacy against COVID-19

DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.

The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.

The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.

“The analysis shows no serious safety concerns,” it said.

It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.

https://www.reuters.com/article/health-coronavirus-emirates/update-1-uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19-idUSL1N2IP09V

Posted by NPRA1985 > 2020-12-09 22:25 | Report Abuse

United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19

TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.

The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.

The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.

The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”

The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.

https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirates-claims-chinas-sinopharm-vaccine-is-100-effective-at-preventing-moderate-and-severe-covid-19/?sh=2a60fb42595c

Posted by NPRA1985 > 2020-12-10 23:55 | Report Abuse

Hong Kong’s Ming Pao daily said in its editorial that there were grounds to believe that the UAE must have been stringent with the review and registration of the Chinese vaccine, given the country’s record of being transparent in its anti-virus policymaking and mass testing.

“The UAE also maintains sound ties with the West so sourcing vaccines from the United States or elsewhere should not be a grave challenge. If the Chinese vaccine is not safe or effective, there is no reason for the UAE to endorse Beijing’s vaccine propaganda and risk its own image and the health of its own people.

“Thus the UAE’s approval and its top leader’s injection of the SinoPharm vaccine have come as a much-needed vote of confidence that will help convince more countries. Diversified supply of vaccines, with viable alternatives from China, is key to ensuring fair and equitable access by poor countries,” said the op-ed.

SinoPharm revealed that senior officials in Egypt and Bahrain also took part in trials held there.

https://asiatimes.com/2020/12/uae-gives-chinese-vaccines-a-shot-in-the-arm/

Posted by NPRA1985 > 2020-12-12 02:26 | Report Abuse

FDA intends to 'proceed towards an authorization' of Covid-19 vaccine, official says, as cases soar

(CNN)The FDA has informed Pfizer it intends "to proceed towards an authorization" of the manufacturer's Covid-19 vaccine, the US Health and Human Services Secretary told ABC on Friday morning, as the country is deep into a worsening health crisis.

The statement comes a day after an FDA panel recommended the agency grant an emergency use authorization for the Pfizer-BioNTech coronavirus vaccine.Other key steps remain, but if those hurdles are cleared, the first vaccinations in the US could happen early next week, HHS Secretary Alex Azar told ABC's George Stephanopoulos.

"The FDA informed Pfizer that they do intend to proceed toward an authorization for their vaccine," Azar told ABC Friday morning.

https://edition.cnn.com/2020/12/11/health/us-coronavirus-friday/index.html

Posted by NPRA1985 > 2020-12-12 15:04 | Report Abuse

Pfizer Vaccine Cleared in U.S., a Landmark in Covid-19 Fight

Pfizer Inc. gained emergency U.S. authorization for its Covid-19 vaccine on Friday, completing an unprecedented scientific sprint that could eventually help bring an end to a pandemic that has killed nearly 300,000 Americans

https://www.bloomberg.com/news/articles/2020-12-12/pfizer-covid-vaccine-wins-u-s-fda-emergency-use-authorization

Posted by NPRA1985 > 2020-12-12 18:05 | Report Abuse

Bursa Malaysia is expected to trend higher next week

https://www.malaymail.com/news/money/2020/12/12/bursa-malaysia-is-expected-to-trend-higher-next-week/1931258

----------------

Bursa Malaysia expected to break 1,700 psychological level

Bursa Malaysia is expected to trend higher next week, with the key FTSE Bursa Malaysia KLCI (FBM KLCI) breaking the psychological level of 1,700, and poised to march into the new year with a big bang.

https://themalaysianreserve.com/2020/12/12/bursa-malaysia-expected-to-break-1700-psychological-level/

Posted by FT1981 > 2021-01-07 11:19 | Report Abuse

this counter not active?

Posted by FT1981 > 2021-01-07 11:20 | Report Abuse

https://app.sinchew.com.my/content/content_2406317.html?type=detail&fileId=2406317&colID=6660

Posted by NPRA1985 > 2021-02-03 22:03 |

Post removed.Why?

Posted by KaiHong > 2021-02-15 15:00 | Report Abuse

this is a stable stock

Posted by Aa01182 > 2021-03-11 23:02 | Report Abuse

Sleeping giant

Posted by jomvalueinvest2 > 2021-05-18 14:39 | Report Abuse

Vaccine counter wave coming ? Kanger seems like more hot now

Posted by Mr.Sm Invest123 > 2021-06-07 18:49 | Report Abuse

Apex Healthcare Bhd
Target price: RM3.33 BUY


AMINVESTMENT BANK RESEARCH (MAY 24): The drag from associated company Straits Apex Sdn Bhd (SA) is expected to ease in the coming quarters. Major customer Smith and Nephew Sales Sdn Bhd, which contributes to about 62% of SA sales, performed the bulk of 1QFY21’s transactions in 4QFY20. Pandemic uncertainty has also led it to delay the bulk of its remaining orders to 2HFY21. Currently, order levels are similar to last year’s.

However, poor utilisation rates at SPP NOVO are expected to keep manufacturing segment margins depressed; therefore, the group is deferring expansion plans until pharmaceutical demand returns.

Meanwhile, rising freight and raw material costs are likely to compress margins in the coming quarters. While ASPs for group brand products remain unchanged, they may rise in the coming quarters. External products have already seen a 6% increase in ASP.

With the Ministry of Health’s (MoH) expenses tied up by the pandemic’s resurgence, the group believes government tenders are hard to come by at the moment. We expect this to normalise in FY22F, as the bulk of the MoH’s mass vaccinations will have already been completed by then. Going forward, we remain positive on Apex’s future prospects as a recovery play.

Posted by wallstreetrookie > 2021-06-10 15:03 | Report Abuse

A Guide to Investing in Healthcare Companies

Low tier: IHH, TopGlove, Supermaxm Pharmaniaga
High tier: YSPSAH, Apex Healthcare, Duopharma

Posted by wallstreetrookie > 2021-06-22 04:55 | Report Abuse

Though the company only gets a small slice of the meat within the pharmaceutical business, manufacturing generic medication remains profitable and attractive for defensive investments.

Posted by wallstreetrookie > 2021-06-24 06:20 | Report Abuse

I like this company

Posted by wallstreetrookie > 2021-06-24 13:02 | Report Abuse

Political instability always presents the best opportunities to buy the dips. When everyone's attention is grabbed by glove companies, it is the perfect chance to buy in alternative healthcare and pharmaceutical companies. And for what's worth, Apex Healthcare is a well-managed company

Posted by wallstreetrookie > 2021-06-24 23:32 | Report Abuse

If you want defensive stocks, this is the one

Posted by CynicalCyan > 2021-06-26 22:29 | Report Abuse

21 years ago, AHEALTH was first listed on the Second Board with around 100 mil in market capitalisation.
21 years later, AHEALTH became one of the most consistent profitable companies on Bursa Main Market with about 1 bil in market capitalisation.

Hats off to such an outstanding Malaysian company. May the next 21 years be even better.

Posted by telurgoreng > 2021-07-15 16:19 | Report Abuse

Apex and YSP are both good defensive counters. But YSP seems to be the better value given the price and dividend yield.

Posted by Hafid > 2021-07-15 16:21 | Report Abuse

PROBLEM IS NO GROWTH